Sort
30,917 grants matching “tumor microenvironment”
Pathways to Cancer Therapeutics
$527,542Susan E Waltz · University Of Cincinnati · T32 · FY2021 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2022 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2025 · CA
Targeting the Hedgehog Pathway in Pediatric Brain Tumors
$527,434Tom Curran · St. Jude Children'S Research Hospital · P01 · FY2011 · CA
Role of circular RNA CDR1as in melanoma
$527,415Eva Hernando · New York University School Of Medicine · R01 · FY2023 · CA
(PQC2) Localization as a determinant of cancer dormancy
$527,391Charles P Lin · Massachusetts General Hospital · R01 · FY2016 · CA
Stromal Regulation of Basal Cell Carcinoma Formation
$527,389Anthony E Oro · Stanford University · R01 · FY2024 · AR
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$527,354Albert Folch · University Of Washington · R01 · FY2023 · CA
CAREER: Integration Research and Education in Engineering Multi-scale Cell-Cell Interactions
$527,109Yubing Xie · Suny At Albany · · FY2009 · ENG
New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma
$526,993John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Dynamic Optical Imaging Biomarkers of Tumor Response to Therapy
$526,893Stefan Alexandru Carp · Massachusetts General Hospital · R01 · FY2018 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$526,891Albert Folch · University Of Washington · R01 · FY2022 · CA
Targeting SMARCA2 as a therapeutic strategy in SMARCA4 mutant lung cancer
$526,882Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Targeting bidirectional signaling in lung stroma and cancer cells
$526,874Uwe Rix · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA
Ex vivo analysis of human brain tumor cells in a microvascular niche model
$526,749Rong Fan · Yale University · R01 · FY2022 · CA
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
$526,721Johannes Zakrzewski · Hackensack University Medical Center · R37 · FY2024 · CA
Tech Core 2
$526,720Denis Wirtz · Johns Hopkins University · U54 · FY2024 · CA
Proton-coupled folate/antifolate transport
$526,718Israel David Goldman · Albert Einstein College Of Medicine · R01 · FY2009 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2025 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Chuan-Yuan Li · Duke University · R01 · FY2021 · CA
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
$526,519Minah Kim · Columbia University Health Sciences · R37 · FY2025 · CA
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str
$526,470Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · CA
Epidermal growth factor mitigates radiation-induced hematopoietic failure
$526,387John P Chute · University Of California Los Angeles · U01 · FY2015 · AI
Project 2
$526,318Paolo Provenzano · University Of Minnesota · P01 · FY2024 · CA
Mechanisms of Hedgehog signaling in glioblastoma
$526,287David R Raleigh · University Of California, San Francisco · R01 · FY2023 · CA